Literature DB >> 11350610

Malignant phyllodes tumor of the breast with expression of osteonectin and vinculin.

N Kuroda1, T Sugimoto, S Ueda, T Takahashi, T Moriki, H Sonobe, E Miyazaki, Y Hayashi, M Toi, M Hiroi, H Enzan.   

Abstract

Phyllodes tumor is a very rare neoplasm which accounts for 2.5% of all fibroepithelial lesions of the breast. The mesenchymal component of a malignant phyllodes tumor frequently contains heterologous components. We report a case of malignant phyllodes tumor. The patient was a 40-year-old woman with a lump on the left breast. Histological examination revealed the lump to be a malignant phyllodes tumor with foci of liposarcomatous differentiation. The mesenchymal tumor cells, including those in the liposarcomatous components, were found to express vimentin, osteonectin and vinculin. However, they showed no immunoreaction to CAM 5.2, desmin, alpha-smooth muscle actin (ASMA), neuron-specific enolase (NSE) nor S-100. Ultrastructurally, the mesenchymal tumor cells were found to have abundant cytoplasmic organelles, but there was no evidence showing their differentiation to myofibroblasts. Further studies will be necessary to elucidate the significance of vinculin and osteonectin expression in malignant phyllodes tumor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350610     DOI: 10.1046/j.1440-1827.2001.01195.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

1.  In phyllodes tumors of the breast expression of SPARC (osteonectin/BM40) mRNA by in situ hybridization correlates with protein expression by immunohistochemistry and is associated with tumor progression.

Authors:  Nah Ihm Kim; Ga-Eon Kim; Ji Shin Lee; Min Ho Park
Journal:  Virchows Arch       Date:  2016-12-01       Impact factor: 4.064

2.  Vinculin regulates cell-surface E-cadherin expression by binding to beta-catenin.

Authors:  Xiao Peng; Laura E Cuff; Cort D Lawton; Kris A DeMali
Journal:  J Cell Sci       Date:  2010-01-19       Impact factor: 5.285

3.  A Case of Phyllodes Tumor of the Breast with Mixed Liposarcoma: Case Report and Literature Review.

Authors:  Mei Er Tu He Ta Mi Shi; Ning Wang; Qing Yao; Shuang-Shuang Dong; Xiao Feng; Jin Zhao; Hong Zou; Li-Juan Pang; Yan Qi
Journal:  Onco Targets Ther       Date:  2021-05-06       Impact factor: 4.147

4.  Radiotherapy with apatinib for recurrence of malignant phyllodes tumor of the breast: A case report.

Authors:  Hong Wu; Lei Li; Jing Yang; Chen Guo; Weiming Zhang; Hui Wang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

5.  Phyllodes tumor of the breast: role of Axl and ST6GalNAcII in the development of mammary phyllodes tumors.

Authors:  Dongliang Ren; Yanyan Li; Yanxin Gong; Jingchao Xu; Xiaolong Miao; Xiangnan Li; Chen Liu; Li Jia; Yongfu Zhao
Journal:  Tumour Biol       Date:  2014-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.